Total synthesis of (+)-crocacin D.Org Lett. 2002 Feb 21; 4(4):525-7.OL
Abstract
[structure: see text] The first asymmetric synthesis of (+)-crocacin D (4) is described. The key steps in the sequence are the stereoselective assembly of the stereotetrad via a substrate-controlled aldol reaction and anti-selective reduction, formation of the (E,E)-diene by a Stille cross-coupling between the stannane 8 and vinyl iodide 9, and the acylation of (Z)-enecarbamate 6 with the acid chloride derived from polyketide fragment 16 which introduced the (Z)-enamide functionality.
Pub Type(s)
Journal Article
Research Support, Non-U.S. Gov't
Language
eng
PubMed ID
11843582
Citation
Feutrill, John T., et al. "Total Synthesis of (+)-crocacin D." Organic Letters, vol. 4, no. 4, 2002, pp. 525-7.
Feutrill JT, Lilly MJ, Rizzacasa MA. Total synthesis of (+)-crocacin D. Org Lett. 2002;4(4):525-7.
Feutrill, J. T., Lilly, M. J., & Rizzacasa, M. A. (2002). Total synthesis of (+)-crocacin D. Organic Letters, 4(4), 525-7.
Feutrill JT, Lilly MJ, Rizzacasa MA. Total Synthesis of (+)-crocacin D. Org Lett. 2002 Feb 21;4(4):525-7. PubMed PMID: 11843582.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Total synthesis of (+)-crocacin D.
AU - Feutrill,John T,
AU - Lilly,Michael J,
AU - Rizzacasa,Mark A,
PY - 2002/2/15/pubmed
PY - 2002/4/16/medline
PY - 2002/2/15/entrez
SP - 525
EP - 7
JF - Organic letters
JO - Org Lett
VL - 4
IS - 4
N2 - [structure: see text] The first asymmetric synthesis of (+)-crocacin D (4) is described. The key steps in the sequence are the stereoselective assembly of the stereotetrad via a substrate-controlled aldol reaction and anti-selective reduction, formation of the (E,E)-diene by a Stille cross-coupling between the stannane 8 and vinyl iodide 9, and the acylation of (Z)-enecarbamate 6 with the acid chloride derived from polyketide fragment 16 which introduced the (Z)-enamide functionality.
SN - 1523-7060
UR - https://www.unboundmedicine.com/medline/citation/11843582/Total_synthesis_of__+__crocacin_D_
L2 - https://doi.org/10.1021/ol017092x
DB - PRIME
DP - Unbound Medicine
ER -